Rating History for 7/9/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics
(Morgan Stanley - Kallum Titchmarsh) |
TXG | Maintain | Equalweight (N/A) |
37.00 (22.00) |
|
Details | |||
| Abbvie
(Guggenheim - Vamil Divan) |
ABBV | Maintain | Buy (N/A) |
261.00 (249.00) |
|
Details | |||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 487 more... | |||||||||


